New Wearable Diagnoses Heart Disease More Accurately
Discover how a next-gen wearable device can improve heart disease diagnosis and transform patient care with enhanced accuracy and efficiency.
Executive Brief
- The News: Peerbridge Health raises $7M.
- Clinical Win: Reduces emergency room visits with early cardiac diagnostics.
- Target Specialty: Cardiologists in primary care clinics.
Key Data at a Glance
Funding Raised: $7M
Product: Cor MDx
FDA Status: Submitted for 510(k) clearance
Launch Timeline: Later this year
New Board Member: Dan Reuvers
Years of Experience: 30
New Wearable Diagnoses Heart Disease More Accurately
What You Should Know:
– Peerbridge Health, a company transforming how heart disease is diagnosed has closed its latest fundraising round, raising $7M to support the commercial rollout of its new product.
– Additionally, it has submitted its next-generation wearable, the Cor MDx™, for FDA 510(k) clearance and appointed medical-technology executive Dan Reuvers to its Board of Directors. It is expected to launch later this year, pending regulatory clearance.
Strengthening Leadership and Expanding Sales
The company has appointed Dan Reuvers to its Board of Directors. Reuvers brings over 30 years of leadership experience in the medical technology industry, having served as CEO of Tactile Medical and president of the neuro division of Integra LifeSciences. Chris Darland stated that Reuvers brings “exactly the kind of experience we need right now as we move into this next phase,” and that his proven ability to scale innovative health technology companies will make him an integral part of the team.
In addition to its leadership appointments, Peerbridge Health has expanded its sales team across three regions with plans to broaden its launch beyond these initial areas. This expansion will focus on bringing hospital-grade cardiac diagnostics into primary care and cardiology clinics with the goal of catching disease as early as possible, which will reduce emergency room visits and improve patient outcomes.
Clinical Perspective — Dr. Kavya Sharma, Cardiology
Workflow: With the launch of Peerbridge Health's Cor MDx, I'll be able to bring hospital-grade cardiac diagnostics into my primary care clinic, which could change my daily routine by allowing me to catch heart disease earlier. The company's expansion plans to bring this technology into primary care and cardiology clinics will likely impact how I assess and manage cardiac patients. This shift could streamline my workflow by providing more accurate diagnoses earlier on.
Economics: The article doesn't address cost directly, but with $7M raised in its latest fundraising round, Peerbridge Health is well-positioned to support the commercial rollout of its new product, which may lead to more affordable cardiac diagnostic options for my patients. As the company expands its sales team, I'd expect to see more information on pricing and cost-effectiveness. For now, it's unclear how this will impact my practice's bottom line.
Patient Outcomes: By bringing cardiac diagnostics into primary care, we're aiming to reduce emergency room visits and improve patient outcomes. While the article doesn't cite specific numbers, the goal of catching disease as early as possible will likely lead to better health outcomes for my patients, and I'm looking forward to seeing the impact of Peerbridge Health's technology on my patient population.
Transparency & Corrections
HCP Connect is funded by Stravent LLC and maintains editorial independence from advertisers and pharmaceutical companies. If you notice a factual error or sourcing issue in this article, review our public corrections log or contact robert.foster@straventgroup.com.